These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7783161)

  • 21. The double-helix derailed: the story of the BRCA patent.
    Matloff ET; Brierley KL
    Lancet; 2010 Jul; 376(9738):314-5. PubMed ID: 20674708
    [No Abstract]   [Full Text] [Related]  

  • 22. [Genetic testing in patients at risk for carcinoma of the breast].
    Kiechle M
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2420-2. PubMed ID: 17054060
    [No Abstract]   [Full Text] [Related]  

  • 23. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 24366402
    [No Abstract]   [Full Text] [Related]  

  • 24. Scale-up technology: moving predictive tests for inherited breast, ovarian, and colon cancers from the bench to the bedside and beyond.
    Holtzman NA
    J Natl Cancer Inst Monogr; 1995; (17):95-7. PubMed ID: 8573464
    [No Abstract]   [Full Text] [Related]  

  • 25. Breast & ovarian cancer. Issues in risk assessment.
    Caro SW
    Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
    [No Abstract]   [Full Text] [Related]  

  • 26. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines.
    Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG
    Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Malignant neoplasm prevention – what do the women want?].
    Vasilev N
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():3-4. PubMed ID: 23236669
    [No Abstract]   [Full Text] [Related]  

  • 28. JAMA patient page. BRCA genes and breast cancer.
    Pluta RM; Golub RM
    JAMA; 2011 Jun; 305(21):2244. PubMed ID: 21632489
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer.
    Lobb E; Meiser B
    Lancet; 2004 Jun; 363(9424):1841-2. PubMed ID: 15183619
    [No Abstract]   [Full Text] [Related]  

  • 30. Issues in the genetic assessment of predispositions for familial breast and ovarian cancer.
    Mark HF; McGowan KD
    Cytobios; 1996; 87(351):229-35. PubMed ID: 9214724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.
    Raphael J; Verma S; Hewitt P; Eisen A
    J Genet Couns; 2016 Dec; 25(6):1309-1316. PubMed ID: 27228984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons learned from genetic testing.
    Esserman L; Kaklamani V
    JAMA; 2010 Sep; 304(9):1011-2. PubMed ID: 20810382
    [No Abstract]   [Full Text] [Related]  

  • 33. Professional challenges in cancer genetic testing: who is the patient?
    Chan-Smutko G; Patel D; Shannon KM; Ryan PD
    Oncologist; 2008 Mar; 13(3):232-8. PubMed ID: 18378533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
    Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
    Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision medicine meets public health: population screening for BRCA1 and BRCA2.
    Levy-Lahad E; Lahad A; King MC
    J Natl Cancer Inst; 2015 Jan; 107(1):420. PubMed ID: 25550384
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):603-6. PubMed ID: 15254451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.
    Macdonald KG; Doan B; Kelner M; Taylor KM
    CMAJ; 1996 Feb; 154(4):457-64. PubMed ID: 8630835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCRA 1 testing guidelines for high-risk patients.
    Sorscher S; Levonian P
    J Clin Oncol; 1997 Apr; 15(4):1711. PubMed ID: 9213589
    [No Abstract]   [Full Text] [Related]  

  • 39. Women's decisions regarding management of breast cancer risk.
    MacDonald DJ
    Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Panel examines impact of public figures on cancer awareness.
    Newman L
    J Natl Cancer Inst; 2001 Jan; 93(1):8-9. PubMed ID: 11136831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.